Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	78.44	23.36	14.47	14.22	32.94
Short-Term Investments	112.97	74.36	37.75	37.93	12.09
Cash & Short-Term Investments	191.4	97.72	52.23	52.15	45.02
Cash Growth	95.87%	87.11%	0.15%	15.82%	-52.62%
Accounts Receivable	6.15	-	-	-	3
Other Receivables	0.57	1.65	2.44	0.19	-
Total Trade Receivables	6.72	1.65	2.44	0.19	3
Inventory	5.49	-	-	-	-
Other Current Assets	1.29	1.48	1.07	0.76	8.27
Total Current Assets	204.91	100.85	55.74	53.1	56.29
Net Property, Plant & Equipment	13.88	7.98	7.99	11.07	21.74
Other Intangible Assets	-	-	-	-	1.38
Other Long-Term Assets	0.78	0.1	0.28	0.04	0.17
Total Assets	219.57	108.93	64	64.21	79.59
Accounts Payable	7.89	3.44	1.86	1.81	4.33
Accrued Expenses	8.59	6.33	5.99	3.99	5.59
Current Portion of Long-Term Debt	12.22	5.93	-	-	-
Current Portion of Leases	0.86	0.82	1	1.77	1.82
Other Current Liabilities	0	0.06	4.58	0.2	4.9
Total Current Liabilities	29.57	16.59	13.42	7.78	16.62
Long-Term Debt	7.81	13.04	-	-	-
Long-Term Leases	4.07	3.26	4.4	5.85	7.56
Other Long-Term Liabilities	18.9	32.01	31.35	23.82	13.04
Total Long-Term Liabilities	30.78	48.31	35.75	29.67	20.6
Total Liabilities	60.35	64.9	49.18	37.45	37.22
Common Stock	0.55	0.46	0.27	0.18	1.47
Additional Paid-in Capital	900.6	856.82	764.15	722.05	696.56
Accumulated Other Comprehensive Income	0.14	0.01	-0.07	-0.13	-0.03
Retained Earnings	-742.08	-813.26	-749.52	-695.34	-655.64
Shareholders' Equity	159.22	44.03	14.83	26.76	42.37
Total Liabilities & Equity	219.57	108.93	64	64.21	79.59
Total Debt	24.97	23.05	5.4	7.63	9.38
Net Cash (Debt)	166.44	74.67	46.83	44.52	35.65
Net Cash Growth	122.89%	59.47%	5.17%	24.90%	-58.70%
Net Cash Per Share	2.52	1.82	2.19	5.66	9.05
Book Value	159.22	44.03	14.83	26.76	42.37
Book Value Per Share	2.41	1.07	0.69	3.40	10.76
Tangible Book Value	159.22	44.03	14.83	26.76	40.98
Tangible Book Value Per Share	2.41	1.07	0.69	3.40	10.41

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q